STADA IRBESARTAN HCT 300/12.5 irbesartan/hydrochlorothiazide 300 mg/12.5 mg tablet blister Australia - English - Department of Health (Therapeutic Goods Administration)

stada irbesartan hct 300/12.5 irbesartan/hydrochlorothiazide 300 mg/12.5 mg tablet blister

medis pharma pty ltd - hydrochlorothiazide, quantity: 12.5 mg; irbesartan, quantity: 300 mg - tablet - excipient ingredients: colloidal anhydrous silica; microcrystalline cellulose; povidone; hydrogenated castor oil; maize starch; magnesium stearate; lactose monohydrate; croscarmellose sodium - stada irbesartan hct is indicated for the treatment of hypertension. treatment should not be initiated with this fixed dose combination.

IRBESARTAN TABLET Canada - English - Health Canada

irbesartan tablet

actavis pharma company - irbesartan - tablet - 300mg - irbesartan 300mg - angiotensin ii receptor antagonists

Irbesartan 300mg film-coated tablets United Kingdom - English - myHealthbox

irbesartan 300mg film-coated tablets

brown & burk uk ltd - irbesartan - film-coated tablets - 300mg - angiotensin-ii antagonists, plain - it is indicated in adults for the treatment of essential hypertension. it is also indicated for the treatment of renal disease in adult patients with hypertension and type 2 diabetes mellitus as part of an antihypertensive medicinal product regimen

KARVEA irbesartan 300 mg film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

karvea irbesartan 300 mg film-coated tablet blister pack

sanofi-aventis australia pty ltd - irbesartan, quantity: 300 mg - tablet, film coated - excipient ingredients: magnesium stearate; microcrystalline cellulose; croscarmellose sodium; lactose monohydrate; silicon dioxide; carnauba wax; hypromellose; titanium dioxide; macrogol 3000 - karvea is indicated for the treatment of hypertension. karvea is indicated for delaying the progression of renal disease in hypertensive type ii diabetics with persistent micro-albuminuria (more than or equal to 30 mg per 24 hour) or urinary protein in excess of 900 mg per 24 hours

Irbesartan 300mg tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

irbesartan 300mg tablets

sandoz ltd - irbesartan - tablet - 300mg

TEVA-IRBESARTAN TABLET Canada - English - Health Canada

teva-irbesartan tablet

teva canada limited - irbesartan - tablet - 300mg - irbesartan 300mg - angiotensin ii receptor antagonists

PMS-IRBESARTAN TABLET Canada - English - Health Canada

pms-irbesartan tablet

pharmascience inc - irbesartan - tablet - 300mg - irbesartan 300mg - angiotensin ii receptor antagonists

PMS-IRBESARTAN-HCTZ TABLET Canada - English - Health Canada

pms-irbesartan-hctz tablet

pharmascience inc - irbesartan; hydrochlorothiazide - tablet - 300mg; 12.5mg - irbesartan 300mg; hydrochlorothiazide 12.5mg - angiotensin ii receptor antagonists

PMS-IRBESARTAN-HCTZ TABLET Canada - English - Health Canada

pms-irbesartan-hctz tablet

pharmascience inc - irbesartan; hydrochlorothiazide - tablet - 300mg; 25mg - irbesartan 300mg; hydrochlorothiazide 25mg - angiotensin ii receptor antagonists

RAN-IRBESARTAN HCTZ TABLET Canada - English - Health Canada

ran-irbesartan hctz tablet

ranbaxy pharmaceuticals canada inc. - irbesartan; hydrochlorothiazide - tablet - 300mg; 12.5mg - irbesartan 300mg; hydrochlorothiazide 12.5mg - angiotensin ii receptor antagonists